Reach Us 44-7452-259145


Evaluations of Motelukast As Add On Therapy (Corticosteroid Sparing Effect) To Inhaled Cortocosteroids In Patients With Chronic Persistent Asthma

WHO recognizes asthma as a disease of major public importance and stimulates research in to the causes of asthma to develop new control strategies and treatment techniques. Inhaled corticosteroid (ICS) used as first line preventive therapy is associated with systemic adverse events. The aim of the study was to improve patient care and therapeutic benefits by including montelukast along with ICS. The corticosteroid sparing properties of montelukast was studied and the efficacy of concomitant montelukast was evident in test group with FEVI value (2.16vs1.73) with improvement in mean day time score and mean asthma free days and reduction in ß agonist use & mean asthma exacerbation days.

Author(s): Narmadha M.P, Jimy John, Nagarajan M, Murugesh N

Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+
30+ Million Readerbase
Recommended Conferences
Google scholar citation report
Citations : 7472

International Journal of Drug Development and Research received 7472 citations as per google scholar report

International Journal of Drug Development and Research peer review process verified at publons
Abstracted/Indexed in
  • Google Scholar
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Publons
  • MIAR
  • ResearchGate
  • University Grants Commission
  • Secret Search Engine Labs
  • Euro Pub

View More »

Flyer image


tempobet giriş

tempobet giriş

tipobet süpertotobet yeni adres süperbahis 747 güvenilir bahis siteleri telefonda sex sohbet

rolex replica